# ZNF620

## Overview
ZNF620 is a gene that encodes the zinc finger protein 620, a member of the KRAB-zinc finger protein family, which is characterized by the presence of zinc finger domains. These domains are essential for the protein's function as a transcription factor, allowing it to bind specific DNA sequences and regulate gene expression. Zinc finger protein 620 plays a crucial role in maintaining the pluripotency and self-renewal of pluripotent stem cells (PSCs) by repressing pro-differentiation genes through interactions with TRIM28, a protein involved in chromatin remodeling and gene silencing (Oleksiewicz2017TRIM28). The expression of ZNF620 is notably higher in induced pluripotent stem cells (iPSCs) compared to differentiated cells, highlighting its importance in the dedifferentiation process. Additionally, ZNF620 has been implicated in kidney renal clear cell carcinoma (KIRC), where its expression levels correlate with patient survival outcomes, suggesting a potential tumor-suppressive role (Czerwinska2021Low).

## Structure
ZNF620 is a member of the zinc finger protein family, characterized by the presence of zinc finger domains. These domains are small protein motifs that coordinate zinc ions, which help stabilize their folds. The primary structure of ZNF620 includes a sequence of amino acids that form these zinc finger motifs, which are crucial for its function as a transcription factor. The secondary structure of ZNF620 may involve the formation of alpha helices and beta sheets, typical of proteins with zinc finger domains. The tertiary structure refers to the overall three-dimensional shape of the protein, which is stabilized by the zinc ions coordinated within the zinc finger domains. 

Post-translational modifications of ZNF620 can include phosphorylation, ubiquitination, and methylation, which may influence its activity and interactions. These modifications are common in proteins that function as transcription factors, as they can regulate the protein's ability to bind DNA and interact with other proteins. ZNF620 may also have splice variant isoforms, resulting in different protein forms with potentially distinct functions. These isoforms can arise from alternative splicing events, which are common in genes encoding transcription factors, allowing for functional diversity.

## Function
ZNF620 is a member of the KRAB-zinc finger protein family, which plays a significant role in the regulation of gene expression through epigenetic mechanisms. In healthy human cells, ZNF620 is primarily involved in maintaining the pluripotency and self-renewal properties of pluripotent stem cells (PSCs). It achieves this by participating in the repression of pro-differentiation genes, thereby preserving the undifferentiated state of stem cells. This repression is mediated through interactions with TRIM28, a protein that facilitates chromatin remodeling and gene silencing (Oleksiewicz2017TRIM28).

ZNF620 is expressed at higher levels in induced pluripotent stem cells (iPSCs) compared to differentiated cells, such as primary human dermal fibroblasts. Its expression increases during the reprogramming of somatic cells to PSCs and decreases during differentiation, indicating its role in the dedifferentiation process (Oleksiewicz2017TRIM28). The protein is active in the nucleus, where it influences transcriptional regulation by binding to specific DNA sequences, impacting cellular processes such as DNA transcription and cell differentiation (Oleksiewicz2017TRIM28). These activities suggest that ZNF620 is crucial for the maintenance of stem cell characteristics and the regulation of developmental pathways.

## Clinical Significance
ZNF620 has been implicated in kidney renal clear cell carcinoma (KIRC), where its expression levels are associated with patient survival outcomes. High expression of ZNF620 is linked to better survival rates, suggesting a potential tumor-suppressive role in KIRC. The study by Czerwinska and Mackiewicz found that ZNF620, along with other KRAB-ZNF proteins, is differentially expressed in tumor versus normal kidney tissue, with some being significantly downregulated and others overexpressed in tumor tissue. This differential expression pattern indicates that ZNF620 may have prognostic value in KIRC (Czerwinska2021Low).

In the context of pluripotent stem cells, ZNF620 is significantly upregulated in induced pluripotent stem cells (iPSCs) compared to fibroblasts. This upregulation suggests that ZNF620 may play a role in maintaining the pluripotency and self-renewal properties of stem cells through epigenetic repression of pro-differentiation genes (Oleksiewicz2017TRIM28). The expression of ZNF620 and its interaction with TRIM28 may contribute to the regulation of cancer stemness and immune modulation in KIRC, potentially impacting the tumor microenvironment and patient prognosis (Czerwinska2021Low).


## References


[1. (Czerwinska2021Low) Patrycja Czerwinska and Andrzej Adam Mackiewicz. Low levels of trim28-interacting krab-znf genes associate with cancer stemness and predict poor prognosis of kidney renal clear cell carcinoma patients. Cancers, 13(19):4835, September 2021. URL: http://dx.doi.org/10.3390/cancers13194835, doi:10.3390/cancers13194835. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13194835)

[2. (Oleksiewicz2017TRIM28) Urszula Oleksiewicz, Marta Gładych, Ayush T. Raman, Holger Heyn, Elisabetta Mereu, Paula Chlebanowska, Anastazja Andrzejewska, Barbara Sozańska, Neha Samant, Katarzyna Fąk, Paulina Auguścik, Marcin Kosiński, Joanna P. Wróblewska, Katarzyna Tomczak, Katarzyna Kulcenty, Rafał Płoski, Przemysław Biecek, Manel Esteller, Parantu K. Shah, Kunal Rai, and Maciej Wiznerowicz. Trim28 and interacting krab-znfs control self-renewal of human pluripotent stem cells through epigenetic repression of pro-differentiation genes. Stem Cell Reports, 9(6):2065–2080, December 2017. URL: http://dx.doi.org/10.1016/j.stemcr.2017.10.031, doi:10.1016/j.stemcr.2017.10.031. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.stemcr.2017.10.031)